Searched for
PFIZER CANDIDATE
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...- Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drugPfizer and 3SBio Inc. have entered into a licensing agreement valued at approximately $6 billion for the development, manufacturing, and co...
- Pfizer to buy 8.1% stake in French vaccines company ValnevaValneva will use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program. ...
- Pfizer, BioNTech begin vaccine trial to target new strainThe study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...
- Pfizer-BioNTech begin trials of new vaccine against Omicron variantThe study will have 1420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech COVID vaccine or an Omicr...
- Pfizer begins testing use of pnuemococcal vaccine along with COVID-19 booster shotThe study will include 600 adults over 65 years who will be recruited from the late-stage study of the Pfizer-BioNTech COVID-19 vaccine, an...
- Pfizer begins early-stage study of oral drug to combat coronavirusThe drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate s...
- Explained: Where does the world stand in the race for a coronavirus vaccine?The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic, which has killed more than 1.8 milli...
- Novavax''s COVID vaccine to be studied in the USThe candidate made by Novavax Inc. is the fifth to reach final-stage testing in the U.S. Some 30,000 volunteers are needed to prove if this...
- Committed to engaging with Indian govt to make vaccine available in country: PfizerThe UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19 with the UK regulator Medicines and He...
- EU regulator could approve Covid vaccines 'late 2020, early 2021'The Amsterdam-based EMA is carrying out "rolling reviews" designed to speed up vaccine approval times on three candidates: Pfizer-BioNTech,...
- Pfizer shares surge nearly 4% on vaccine reportGlobal drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis o...
- Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists sayThe decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...
- Govt pins hopes on 5 Covid shots under trial in IndiaNiti Aayog member Dr V K Paul, who also heads the national expert group on vaccine administration, said all these vaccines were on easy pla...
- India health authorities betting on AstraZeneca, Bharat Biotech vaccines“India will have to focus on the indigenous vaccines and the AstraZeneca-Oxford vaccine. These vaccines are being tested in the India popul...
- Croda strikes deal with Pfizer to supply COVID-19 vaccine additivesThe contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the producti...
- UK says expects to receive 10 million doses of Pfizer/BioNTech vaccine this yearThe spokesman said that Britain had now ordered 40 million doses of the candidate vaccine developed by Pfizer and BioNTech, one of six that...
- Pfizer not yet ready to release COVID-19 vaccine data from late-stage trialPharma major Pfizer Inc said the company could release data on whether or not the vaccine works as early as this month.
- U.S. to pay Pfizer and BioNTech $1.95 billion to produce millions of doses of COVID-19 vaccinePfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, ...
- Pfizer halts cholesterol drug trial, shares may take a hitPfizer’s shares will likely plunge after the world’s biggest drugmaker unexpectedly ended development of its most important new drug, a cho...
Load More
